Acumen Pharmaceuticals Company Insiders

Acumen Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.2099) % which means that it has lost $0.2099 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3283) %, meaning that it created substantial loss on money invested by shareholders. Acumen Pharmaceuticals' management efficiency ratios could be used to measure how well Acumen Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.16 in 2025. Return On Capital Employed is likely to gain to -0.19 in 2025. At this time, Acumen Pharmaceuticals' Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 227.9 M in 2025, whereas Other Current Assets are likely to drop slightly above 2.4 M in 2025. Common Stock Shares Outstanding is likely to drop to about 46.2 M in 2025. Net Loss is likely to drop to about (40.5 M) in 2025

Acumen Pharmaceuticals Workforce Comparison

Acumen Pharmaceuticals Insider Trading

Acumen Pharmaceuticals Notable Stakeholders

The success or failure of an entity such as Acumen Pharmaceuticals often depends on how effective the management is. Acumen Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Acumen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Acumen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Acumen Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Acumen Pharmaceuticals. Check Acumen Pharmaceuticals' Beneish M Score to see the likelihood of Acumen Pharmaceuticals' management manipulating its earnings.

When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.